4baseCare, a precision oncology company in India, has announced a collaboration with Cellworks Group, Inc., a US-based company. As a part of this association, the organisations will further their capabilities in personalised cancer care and treatment strategy based on advanced clinical insights through genomics-based molecular profiling and biosimulation, according to a statement.
Speaking on the strategic collaboration, Hitesh Goswami, CEO, 4baseCare, said, “We are constantly working towards delivering our promise of precision medicine to help personalise the treatment for Indian cancer patients. With this collaboration, for the first time, Indian oncologists would have access to the most advanced bio-simulation based molecular reports for personalising treatment of their cancer patients.”
“We look forward to collaborating with 4baseCare and utilising TarGT Absolute to provide oncologists in India with personalised therapy predictions that improve patient outcomes,” said Michele Macpherson, Chief Business Officer at Cellworks Group.
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.